Researchers at UCSF and UC Davis teamed up to study one of the most aggressive cancers in cats: squamous cell carcinoma.

Most cats survive only two to three months after diagnosis.

Teams tested a drug that blocks the protein STAT3, which is responsible for growing cancer cells.

More than a quarter of the cats tested lived months longer than expected.

Researchers believe the drug could also be effective for humans with head and neck cancer, as well as other diseases.

UCSF doctors Daniel Johnson and Jennifer Grandis, who specialize in head and neck surgery and authored this study, joined NBC Bay Area’s Raj Mathai to discuss their findings.

See Full Page